Key Record Dates
| ClinicalTrials.gov Identifier: | NCT05797831 |
|---|---|
| Brief Title: | Study of Navtemadlin as Maintenance Therapy in TP53WT Advanced or Recurrent Endometrial Cancer |
| First Submitted : | March 7, 2023 |
| First Submitted that Met QC Criteria : | March 21, 2023 |
| First Posted : | April 4, 2023 |
| Last Update Submitted that Met QC Criteria : | April 30, 2024 |
| Last Update Posted : | May 2, 2024 |